34 funding opportunities are listed in this category
Friedreich's Ataxia Research Alliance New Investigator Grants
These grant awards are for young or new investigators who have demonstrated an interest in FA research and want to further that commitment. We believe in welcoming, mentoring and supporting new scientists in the FA research community so that they have the necessary experience and motivation to launch successful independent careers. Guidelines for New Investigator Grants New Investigator Grants are accepted twice a year March 1st and September 1st then awards are announced June 1st and December 1st. The terms of the awards are July 1 – June 30 for awards submitted March 1st and January 1 – December 31 for awards submitted September 1st. Grant proposals should not exceed 24 months in duration. Grant awards are made in one year allocations. All subsequent payments are contingent upon receipt and satisfactory review of a progress report. FARA reserves the right terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in funding priority. All grants should be submitted using FARA’s Research Portfolio Management Program – www.curefa.org/rpmp On the Main Grant Page of the application please indicate “NIA” in the RFP field. A letter of support should be provided by the applicant’s supervisor/advisor. A personal statement from the applicant should also be included that addresses the applicant’s current interests, career goals and interest in Friedreich’s ataxia research. FARA only funds direct costs. No indirect costs will be awarded. A detailed budget must be submitted with all proposals, including a justification to support reported expenses. Reasonable and customary salary support and benefits are acceptable for the applicant. The budget should not exceed $100,000. Additional allowable expenses include: laboratory reagents and supplies, equipment, animal expenses, patient expenses directly related to study and not reimbursable by third party insurers, patient travel Expenses not awarded: indirect costs/overhead, travel to meetings and conferences, membership to scientific societies Individuals who receive this award cannot reapply through this same mechanism. This award is intended to help the scientist achieve additional sources of funding and independence. If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB). Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FARA. If animals are used in the proposed study, the study must be approved by the Institutional Animal Care and Use Committee (or equivalent) indicating that appropriate precautions have been taken to assure that proper treatment, care and humane conditions have been provided.
Friedreich's Ataxia Research Alliance 102 Pickering Way, Suite 200 Exton, PA 19341 USA Phone: (484) 875-3015 Fax: (610) 363-1506 Email: info@cureFA.org Website: www.cureFA.org
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
Grant submission deadline is April 1, 2010 Two, CBD-related grants are available for up to $75,000 for a period of one to two years
VISION Cure and prevent PSP and CBD
MISSION STATEMENT Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.
The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
INVESTIGATOR-INITIATED RESEARCH CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.
CurePSP is particularly interested in research that will help us: 1. Understand the role of the tau gene and other genes in PSP and CBD. 2. Understand the role of tau protein processing in PSP and CBD. 3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD. 4. Understand environmental factors that influence the development or course of PSP and CBD. 5. Understand the series of changes brain cells pass through in PSP and CBD as they progress from healthy neurons to dysfunctional neurons. 6. Characterize the natural history of PSP and CBD in order to develop outcome measures for clinical trials. 7. Develop animal models of PSP and CBD. 8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment of treatment. 9. Develop treatments that improve the symptoms of persons with PSP and CBD. 10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
CurePSP Executive Plaza III 11350 McCormick Road, Suite 906 Hunt Valley, MD 21031 Phone: 800-457-4777 E-mail: info@curepsp.org Website: www.curepsp.org
Cure Congenital Muscular Dystrophy Research Grants
Cure CMD Research Grant GoalsCure CMD research goals reflect our mission to bring research, treatments and in the future, a cure for the congenital muscular dystrophies. 1. Identify new therapeutic targets in the CMDs 2. Identify small molecule compounds that work at these therapeutic target sites with priority towards drugs with existing pediatric FDA approval 3. Facilitate the drug development process to ensure that each positive drug identification with promising preliminary data can be brought rapidly to preclinical trials and subsequent treatment trials 4. Support and endorse clinical research, infrastructure and biomarker discovery required to launch effective and efficient clinical trials in rare disease 5. Advance drug discovery with a diverse treatment pipeline 6. Support new scientific investigators with innovative ideas and a commitment to CMD researchStruggle Against Muscular Dystrophy (S.A.M) CMD Translational Research Grant: Annual Deadline, Sept 15th.
S.A.M is a unique CMD advocacy group launched by two parents whose son has CMD. SAM’s focus is to support and foster CMD research through successful fundraising initiatives. The SAM Translational Research Award delivers upon its promise to target research focused on CMD treatment. The grant is made possible through Cure CMD and SAM collaboration and the Cure CMD research grant funding mechanism.Cure CMD and SAM invite proposals to award a 1-2 year grant focusing on pre-clinical and clinical investigations that will advance treatment for congenital muscular dystrophy (CMD). The total award is limited to $100,000 (direct costs only). Annual RFA deadline Sept 15th. Grant application above. On the First Page of the Cure CMD grant application, please specify S.A.M. CMD Translational Research Grant
Cure CMD General Research Grants: Annual Deadline Sept 15th.
Elisabeth Giauque Short Term CMD Research Grant: Cure CMD provides a short-range or “seed” grant (usually $25,000- $50,000 per year for 1-2 years, direct costs only) to attract new investigators to the CMD field and assist existing investigators to support early phases of their research. The short-range grant focus is to collect preliminary data and test initial hypotheses. The short-range grant goal is to translate successful preliminary research to either second tier Cure CMD midrange grants (R-21 type) or third tier, long range (R-01 grants, 2-5 years) from outside funding sources, such as the National Institutes of Health. Annual RFA deadline, Sept 15th. Grant application above. On the first page of the Cure CMD grant application, please specify Elisabeth Giauque Short Term CMD Research Grant.
info@curecmd.comCure CMDP.O. Box 701Olathe, KS 66051Ph. 1-866-400-3626
Benign Essential Blepharospasm Research Foundation, Inc. Request for Research Grant Proposals
Deadline for Submitting Request: August 31, 2010
* Funds up to $150,000 are available for support of research directly related to blepharospasm or Meige's Syndrome, both forms of cranial dystonia * M.D. or Ph.D. required for principal investigator * Non-U.S. citizens, working at institutions abroad are also eligible to apply for a research grant * Research proposals must relate specifically to benign essential blepharospasm and Meige to include new treatments, pathophysiology and genetics, photophobia and dry eye. * If a grant is awarded, we expect a semiannual progress report * Deadline to apply is August 31 each year. Benign Essential Blepharospasm Research Foundation, Inc. P.O. Box 12468 Beaumont, TX 77726-2468 Tel: (409) 832-0788 Fax: (409) 832-0890 E-mail: bebrf@blepharospasm.org
Batten Disease Support and Research Association 2010 Request for Proposals
THe 2010 Request for Proposal is now available. Submitted proposals must be postmarked no later than 11:59PM , May 15, 2010. Emailed proposals will NOT be accepted. Inquiries may be directed to Lance W. Johnston, Executive Director, BDSRA, at 1-800-448-4570 or 740-927-4298. Email address: bdsra1@bdsra.org.
The Batten Disease Support and Research Association (BDSRA) is pleased to announce that limited funds are available to promote research and/or assist in a viable research project/s primarily for, but not limited to, development of novel therapeutic approaches to treatment for Neuronal Ceroid Lipofuscinosis, including the identification of bioactive compounds and characterization of cell-based therapeutic strategies, neuroimaging, proteomic and genomic approaches, and development of treatments that will alleviate the symptoms of Batten Disease. Also approaches exploring the neurobiology of NCL disease and determining the molecular pathogenesis in the CNS and further understanding the cell biology of the NCL proteins/enzymes. Proposals will be received for all forms of NCL with emphasis on CLN1, CLN2, and CLN3. Multiyear proposals are generally discouraged unless there are extenuating circumstances or the study/project requires it.BDSRA is including in its 2010 Request for Proposals, the establishment of a new postdoctoral fellowship. Proposals must include the percentage of time the candidate will expend on the project. Proposal must also include letter from established scientist or lab in which the posdtdoc will be working acknowledging the applicants position. Note: Funding for second and/or third year will be predicated on review of previous work and likelihood of achieving goals. Funding will not accompany if individual changes institution or lab unless preauthorized by BDSRA.All grant award(s) must be used to cover direct costs of the project/ investigation and may not be used for indirect or overhead costs. All awards, including Postdoctoral fellowship, will be paid in six (6) month increments based on report submitted for review. In the event of any changes, such changes will be announced on the BDSRA website - http://www.bdsra.org.
Batten Disease Support and Research Association166 Humphries Dr.Reynoldsburg, OH 43068
National Ataxia Foundation Young Investigator Award
Letter of Intent Due Date: August 1, 2010Application due: September 1, 2010
The Young Investigator Award was created to encourage young clinical and scientific investigators to pursue a career in the field of ataxia research. It is our hope that ataxia research will be invigorated by the work of young, talented individuals supported by this award. Candidates must have attained an MD or PhD degree, and have an appointment as a junior faculty member.
Individuals at the Associate Professor level are not eligible. Clinicians must have finished their residency no more than five (5) years prior to applying. Each recipient will receive a one-year $35,000-$50,000 award. This award will be made to the sponsoring institution and will be used as salary support or for direct research expenses. Awards are for direct cost only, not for indirect costs or institutional overhead.
The sponsoring institution must agree in writing to the following provision: a clinical investigator (MD) must befree to allocate a minimum of half time (50%) for a project; a non–clinician investigator (PhD) must allocate a minimum of three-fourths time (75%) for the project. Periodic progress reports may be required.
Due to the larger availability of funding for Ataxia-Telangiectasia (A-T), those research proposals will receive a lower priority. However, a higher ranking will be given to those Ataxia-Telangiectasia research studies which lend themselves to an overall better understanding of the ataxia process.
National Ataxia Foundation2600 Fernbrook Lane Suite 119Minneapolis, MN 55447-4752Phone: (763)553-0020Fax: (763) 553-0167E-Mail: naf@ataxia.org
National Ataxia Foundation Research Fellowship Award
Letter of Intent Due Date: August 15, 2010Application due: September 15, 2010
NAF research awards are for new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias.
Post-doctoral fellowship awards are to serve as a bridge from postdoctoral positions to junior faculty positions.
Applicants should have completed at least one year of post-doctoral training, but not more than two at the time of application, and should have shown a commitment to research in the field of ataxia. The award will permit individuals to spend an additional third year in a post-doctoral position and increase chances to establish an independent ataxiaresearch program. A letter from the mentor should outline a program of studies for the applicant, and delineate the candidate’s future plans.
It is anticipated that the average funds granted will be up to $35,000.
National Ataxia Foundation has a policy that prohibits indirect costs being applied to NAF grant awards.
National Ataxia Foundation Research Grant
Letter of Intent Due Date: July 15, 2010Application due: August 15, 2010
In its continuing efforts to find the cause, treatment, and cure for the ataxias, the National Ataxia Foundation(NAF) provides limited, short-term financial support of ataxia research.NAF research grants are for new and innovative studies that are relevant to the cause, pathogenesis or treatmentof the hereditary or sporadic ataxias.
Due to the larger availability of funding for Ataxia- Telangiectasia (A-T), those research proposals willreceive a lower priority. However, a higher ranking will be given to those Ataxia-Telangiectasia research studies which lend themselves to an overall better understanding of the ataxia process.
Research grants are offered primarily as “seed monies” to assist investigators in the early or pilot phase of their studies and as additional support for ongoing investigations on demonstration of need. It is hoped that these studies will be further developed to attract future funding from other sources. Grants are awarded for one year only. If funding for a second year is desired then another grant application should be submitted for that funding period.
The average funds granted will be up to $15,000 but funding may be considered for up to $30,000 for projectsdeserving special consideration.
The Huntington’s Disease Society of America’s 2010 – 7th Annual National Youth Alliance National Convention Scholarship
The Huntington’s Disease Society of America is pleased to announce it is now accepting applications for HDSA’s 2010 – 7th Annual National Youth Alliance (NYA) National Convention Scholarship.
The intent of this scholarship is to help active members of the NYA, living with Huntington’s Disease, attend the HDSA NYA Day on Thursday, June 24, 2010 and the HDSA National Convention on June 25-27th in Raleigh, NC.
This Fund was established to benefit all current members of the NYA and exists because of the support and generosity of families at the NYA Silent Auction and other events held at the annual HDSA National Convention, as well as fundraising efforts by NYA members throughout the year.
Scholarship Availability & ApplicationThe scholarship is open to any current or alumni member of the NYA. You must be a registered member of HDSA’s NYA to apply. Membership information is available at www.hdsa.org/nya
All Scholarship recipients are required to attend NYA Day on Thursday, June 24, 2010as well as all pertinent workshops and NYA activities planned during the course of the National Convention. You will also be expected to file a report on some aspect of NYA Day or the Convention to be posted on the NYA website within 30 days of returning from the convention.
The 2010 NYA Scholarship Application follows this introduction. The application is also available on-line from the HDSA website (www.hdsa.org/nya). (Forms printed from that website should be printed in “portrait” setting.)
What does the scholarship cover?• A Full Scholarship:A full scholarship recipient will receive funding to cover round-trip airfare, hotel accommodations (you may be asked to share a room with other scholarship recipients) and convention registration (which covers all workshops for two days and Convention Gala).
• A Partial Scholarship:A partial scholarship recipient will receive funding to cover one of the following:-Round-trip airfare-Hotel Accommodations-Convention Registration (which covers all workshops for two days and Convention Gala).Application Deadline: Applications must be post-marked no later than midnight, Friday, March 19, 2010. Theapplication, essay and all required signatures are to be mailed to:
NYAHuntington’s Disease Society of America505 Eighth Avenue, Suite 902New York, N.Y. 10018Attention: Mynelly PerezNotification of WinnersApplicants will be notified no later than April 5, 2010 as to the status of their application.
1234next
